131 related articles for article (PubMed ID: 32515880)
1. Mechanisms for increased risk of diabetes in chronic liver diseases.
Svegliati-Baroni G; Gaggini M; Carli F; Barbieri C; Cucco M; Youne R; Rosso C; Bugianesi E; Gastaldelli A
Liver Int; 2020 Oct; 40(10):2489-2499. PubMed ID: 32515880
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD.
Coccia F; Testa M; Guarisco G; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):106-113. PubMed ID: 31677889
[TBL] [Abstract][Full Text] [Related]
3. The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease.
Morio R; Hyogo H; Hatooka M; Morio K; Kan H; Kobayashi T; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Aikata H; Ochi H; Masayasu Y; Chayama K
J Gastroenterol; 2017 Feb; 52(2):253-262. PubMed ID: 27351871
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
[TBL] [Abstract][Full Text] [Related]
6. Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker.
Firneisz G; Varga T; Lengyel G; Fehér J; Ghyczy D; Wichmann B; Selmeci L; Tulassay Z; Rácz K; Somogyi A
PLoS One; 2010 Aug; 5(8):e12226. PubMed ID: 20805868
[TBL] [Abstract][Full Text] [Related]
7. Deterioration of insulin release rate response to glucose during oral glucose tolerance test is associated with an increased risk of incident diabetes in normal glucose tolerance subjects.
Li Y; He S; Sun Y; Li G; Xu Q; Wang C; Jia W
IUBMB Life; 2017 Sep; 69(9):756-766. PubMed ID: 28762247
[TBL] [Abstract][Full Text] [Related]
8. Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease.
Grancini V; Trombetta M; Lunati ME; Zimbalatti D; Boselli ML; Gatti S; Donato MF; Resi V; D'Ambrosio R; Aghemo A; Pugliese G; Bonadonna RC; Orsi E
J Hepatol; 2015 Dec; 63(6):1484-90. PubMed ID: 26297917
[TBL] [Abstract][Full Text] [Related]
9. Impact of steatosis on insulin secretion in chronic hepatitis C patients.
Narita R; Abe S; Tabaru A; Otsuki M
Am J Gastroenterol; 2007 Oct; 102(10):2173-80. PubMed ID: 17680843
[TBL] [Abstract][Full Text] [Related]
10. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
Henninger J; Hammarstedt A; Rawshani A; Eliasson B
BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
[TBL] [Abstract][Full Text] [Related]
11. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
[TBL] [Abstract][Full Text] [Related]
12. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
Guo M; Xi G; Yang N; Yao H
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
[TBL] [Abstract][Full Text] [Related]
14. Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease.
Sesti G; Hribal ML; Fiorentino TV; Sciacqua A; Perticone F
BMJ Open Diabetes Res Care; 2014; 2(1):e000016. PubMed ID: 25452862
[TBL] [Abstract][Full Text] [Related]
15. Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD).
Hatziagelaki E; Herder C; Tsiavou A; Teichert T; Chounta A; Nowotny P; Pacini G; Dimitriadis G; Roden M
PLoS One; 2015; 10(5):e0124935. PubMed ID: 25933030
[TBL] [Abstract][Full Text] [Related]
16. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
Viswanathan V; Clementina M; Nair BM; Satyavani K
J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
[TBL] [Abstract][Full Text] [Related]
17. Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes.
Lemieux S; Bédard A; Piché MÈ; Weisnagel SJ; Corneau L; Bergeron J
Clin Endocrinol (Oxf); 2011 Mar; 74(3):340-5. PubMed ID: 21092050
[TBL] [Abstract][Full Text] [Related]
18. Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.
Li Z; Lin M; Liu C; Wang D; Shi X; Chen Z; Liu Y; Yang S; Li X
Cytokine; 2018 Aug; 108():145-150. PubMed ID: 29609136
[TBL] [Abstract][Full Text] [Related]
19. Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose.
Maagensen H; Junker AE; Jørgensen NR; Gluud LL; Knop FK; Vilsbøll T
J Clin Endocrinol Metab; 2018 May; 103(5):2042-2049. PubMed ID: 29506157
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?
Gastaldelli A
Clin Sci (Lond); 2017 Nov; 131(22):2701-2704. PubMed ID: 29109303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]